Real-world experience with caplacizumab in the management of acute TTP
Tina Dutt(University of Liverpool), Marie Scully(University College London Hospitals NHS Foundation Trust), John D. Grainger(Manchester University NHS Foundation Trust), Maeve P. Crowley(Cork University Hospital), Gillian Lowe(University Hospitals Birmingham NHS Foundation Trust), Joanna Haughton(Mid Yorkshire Hospitals NHS Trust), Phillip L.R. Nicolson(University of Birmingham), Joannes Hermans(Nottingham University Hospitals NHS Trust), Jun Yong(University of Liverpool), Nicole Priddee(NHS Lothian), Michael Desborough(Guy's and St Thomas' NHS Foundation Trust), Quentin A. Hill(Leeds Teaching Hospitals NHS Trust), Cheng‐Hock Toh(University of Liverpool), A. E. Taylor(Great Ormond Street Hospital), L. Humphrey(University Hospitals Bristol NHS Foundation Trust), Toby A. Eyre(Churchill Hospital), Tanya Cranfield(Portsmouth Hospitals NHS Trust), Matthew Stubbs(University College London Hospitals NHS Foundation Trust), John Hanley(Newcastle upon Tyne Hospitals NHS Foundation Trust), Hamish Lyall(Norfolk and Norwich University Hospitals NHS Foundation Trust), Susan Rhodes(NHS Greater Glasgow and Clyde), Alexandros Rampotas(Oxford Health NHS Foundation Trust), William Thomas(James Hutton Institute), Steven Lane(University of Liverpool), Oliver Tomkins(University College London Hospitals NHS Foundation Trust), Muhammad Mohsin(Bradford Teaching Hospitals NHS Foundation Trust), Rachel Rayment(University Hospital of Wales), Joost J. van Veen(Sheffield Teaching Hospitals NHS Foundation Trust), Rebecca Shaw(University of Liverpool), Richard Gooding(University Hospitals of Leicester NHS Trust), Benjamin Bailiff(University Hospitals Coventry and Warwickshire NHS Trust)
Cited by 157
Related Papers
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
|British Journal of Haematology|2012|861
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
|The Lancet|2021|454
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura
|Blood|2011|420
Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features
|British Journal of Haematology|2008|376